Diffuse large B-cell lymphoma in a patient with rheumatoid arthritis treated with infliximab and methotrexate . DB00065 is a tumour necrosis factor ( P01375 ) -alpha blocking drug classified as a biological response modifier . It has been suggested that the risk of malignancies , especially lymphomas , is increased in patients with rheumatoid arthritis ( RA ) treated with anti- P01375 antibody therapy . We present a case of malignant lymphoma during the treatment of RA with infliximab and methotrexate .